| Cat.No. | Name | Information |
|---|---|---|
| M2206 | TH-302 (Evofosfamide) | TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM. |
| M6098 | Baicalein | Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor, IC50 value of 3.12 mM. |
| M9325 | EGTA | EGTA is a specific calcium chelator with a Kd of 60.5 nM at physiological pH (7.4) and a high specificity for Ca2+ than for Mg2+.EGTA significantly inhibits the substrate adhesion capacity of inflammatory macrophages. |
| M9330 | Brij-35 | Brij-35 (Polidocanol) is a high HLB, ethoxylated, nonionic ether of lauryl alcohol with broad pH stability. |
| M6154 | 2-PMPA tetrasodium | 2-PMPA (PMPA tetrasodium salt) is a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII) with an IC50 of 300 pM. |
| M2250 | Pamidronate disodium | Pamidronate disodium is a nitrogen containing bisphosphonate, used to the research of preventing osteoporosis. |
| M9916 | DPPH | DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable free radical that measures the free radical scavenging activity of antioxidants. |
| M9194 | Insulin (human) | Insulin (human) is a polypeptide hormone that regulates the level of sugar (glucose) in the blood and is produced by beta cells of islets. |
| M3409 | Formestane | Formestane is a second generation selective aromatase inhibitor with an IC50 of 80 nM. |
| M9665 | N-(2-amino-2-oxoethyl)acrylamide | N-(2-Amino-2-oxoethyl)acrylamide |
| M50429 | Suc-AEPF-AMC | Suc-AEPF-AMC is a peptide substrate of Pin1 and Par14 peptidyl prolyl isomerase. |
| M50413 | Trichomide A | Trichomide A is a potent activator of SHP2. |
| M50412 | CD31 | CD31 (PECAM-1) is platelet endothelial cell adhesion molecule-1, serves as the endothelial cell-specific receptor of clostridium perfringens b-Toxin (CPB). |
| M50245 | N6-(3-Trifluoromethylbenzyl)adenosine | N6-(3-Trifluoromethylbenzyl)adenosine is a potent antiviral agent with EC50 values of 0.101, 19.9, and 91.2 µM for EV71, CVA21, and EV68, respectively.In addition, N6-(3-Trifluoromethylbenzyl)adenosine inhibited METTL3/METTL14 activity in a dose-dependent manner. In addition, N6-(3-Trifluoromethylbenzyl) adenosine inhibited METTL3/METTL14 activity in a dose-dependent manner. |
| M50242 | Perogol O | Perogol O is a 15-unit condensation of oxyethylene with oleyl alcohol and is also a nonionic surfactant. |
| M50235 | MZ-101 | MZ-101 is an orally active and selective inhibitor of small molecule glycogen synthase (GYS1) that reduces glycogen accumulation in skeletal muscle of a mouse model of Pompe disease. |
| M50226 | ABI-H2158 | ABI-H2158 is an HBV capsid inhibitor that indirectly inhibits cccDNA. |
| M50225 | EDP-514 | EDP-514 is a novel HBV capsid inhibitor that prevents the formation of cccDNA from scratch. |
| M50224 | TFC-1326 | TFC-1326 is a novel compound based on natural antifreeze glycoproteins from polar fish with antiaging activity, which can be used in aging-related studies. |
| M50220 | SL-4 | SL-4 is a WRN inhibitor that can be used in studies related to gastrointestinal tumors. |
| M50211 | AL-002 | AL-002 is a humanized monoclonal antibody targeting myeloid triggered receptor 2 (TREM2) that improves cell survival and proliferation and increases microglia activity by activating TREM2 signaling, and can be used in studies related to Alzheimer's disease (AD). |
| M50203 | BAY-2927088 | BAY-2927088 is a selective dihydroorotic acid dehydrogenase (DHODH) inhibitor and tyrosine kinase inhibitor (TKI) that acts by blocking the activity of proteins of EGFR and/or HER2.BAY-2927088 can be used in studies related to non-small cell lung cancer (NSCLC). |
| M50202 | Gadoquatrane | Gadoquatrane is a highly stable magnetic resonance imaging (MRI) contrast agent with high relaxivity. |
| M50201 | BAY-3401016 | BAY-3401016 is a monoclonal antibody targeting SEMA3A for studies related to Alport syndrome. |
| M50200 | BAY-3018250 | BAY-3018250 is a monoclonal antibody targeting α2-antifibrinolytic enzyme (A2AP) for use in studies related to cardiovascular disease. |
| M50185 | EP547 | EP547 is a first-in-class, orally active small molecule antagonist of MRGPRX4 for use in studies related to cholestatic and uremic pruritus. |
| M50184 | Berberine ursodeoxycholate | Berberine ursodeoxycholate is an ionic salt of Berberine and Ursodeoxycholic acid and an orally effective lipid modulator that significantly reduces hepatic fat content.Berberine ursodeoxycholate has been used in studies related to hyperlipidemia, non-alcoholic steatohepatitis (NASH) and diabetes. |
| M50183 | Volixibat | Volixibat is a highly selective, low-absorbed, competitive inhibitor of the apical sodium-dependent bile acid transporter (ASBT) for studies related to non-alcoholic steatohepatitis (NASH). |
| M50178 | GDC-3280 | GDC-3280 is an orally active, potentially best-in-class (BIC) compound further optimized from the chemical structure of pirfenidone for use in studies related to idiopathic pulmonary fibrosis (IPF). |
| M49917 | Polaprezinc | Polaprezinc is an orally bioavailable chelate composed of zinc and L-carnosine, with potential gastroprotective, anti-oxidant, anti-ulcer and anti-inflammatory activities. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
